Dicerna Pharmaceuticals News Pharma Roche

Roche to Pay $200 Million for Rights to RNAi Hepatitis B Drug

Biotech News | 31.10.2019

The Basel-based Swiss pharmaceutical company Roche is spending $200 million for a global licensing...